Pilot intervention looks at ways to bridge gaps in survivorship care, empowering young Latino men to manage distress and reclaim meaningful life goals after cancer treatment.
The veteran researcher receives inaugural award
20221027104337.jpg&width=300&height=300)
Prostate cancer is the second most commonly diagnosed cancer in men (behind skin cancer), with varying levels of aggressiveness. It’s also the second leading cause of cancer death, behind only lung cancer. A new study led by Yale Cancer Center researchers at Yale School Medicine found a substantial increase in the adoption of active surveillance (AS) and watchful waiting (WW) treatment strategies over the past decade — an encouraging trend for men seeking less invasive treatment options.
Potentially deadly mathematical errors are prevalent among mobile applications used in clinical and emergency room settings, but a team of researchers at New Jersey Institute of Technology's Ying Wu C...
The standard treatment for head and neck cancer, cisplatin, can’t be given to some patients due to pre-existing conditions. A new study compares the efficacy of two alternatives: cetuximab, a monoclonal antibody, and durvalumab, an immune checkpoint inhibitor.
A research team at UVA Health is testing the ability of focused ultrasound to increase the immune response to immunotherapy in melanoma. UVA’s work with focused ultrasound already has led to life-changing new treatments for Parkinson’s disease and essential tremor and pushed the technology to the forefront of medical research.
A UCLA study helps explain why glioblastoma, one of the most aggressive forms of brain cancer, becomes resistant to treatment, and introduces a new approach that paves the way for more personalized treatment strategies for patients with this deadly brain tumor.
Scientists have long been trying to tease apart hepatitis A virus, to understand its inner workings and how it functions in the human body. Infectious disease researchers at the UNC School of Medicine have discovered that a little-known protein, PDGFA-associated protein 1 (PDAP1), is used as a pawn by hepatitis A virus to replicate and infect cells in the liver.
The Wistar Institute scientists have discovered a new approach to treating ovarian cancer that, in preclinical laboratory testing, shrinks tumors and improves survival rates while simultaneously making tumors more receptive to chemotherapy treatment.
New research from Memorial Sloan Kettering Cancer Center (MSK)& investigates how pancreatic cancer cells regulate their genome to avoid immune attack; shows promise against glioblastoma in mouse models; and develops a new method to study cancer evolution.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
As director of the Division of Thoracic Surgery in the Jim and Eleanor Randall Department of Surgery at Cedars-Sinai, Harmik J. Soukiasian, MD, and his colleagues are on the forefront of surgical innovations for patients with early-stage lung cancer.
Dozens of physician-scientists will share research insights at ASH 2024, a breast-cancer survivor chronicles her journey, researchers seek answers for gastric cancer disparities, and taking major steps to reduce lung cancer’s lethal burden are in this month tip sheet from Sylvester Comprehensive Cancer Center.
The University of Texas MD Anderson Cancer Center today was awarded nearly $8 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of faculty recruitment as well as lung and colorectal cancer screening and early detection programs to address cancer incidence rates across Texas.
As a young man in his mid-20s, Jorge Gómez was one of thousands of Cuban citizens who fled Communism and the island country on a raft in 1994. He would spend 11 months living in a tent city at Guantanamo Bay before being granted asylum into the U.S., where he overcame countless obstacles to build a better life as an engineer and father of four boys. Patience, perseverance, and an eternal sense of optimism sustained him throughout his journey, he says. And it served him well in 2021 when, during a routine visit to his primary care physician, a cancerous growth in his esophagus was discovered. Heeding his doctor’s recommendation, he sought the help of Markus Goldschmiedt, M.D., Clinical Associate Professor of Internal Medicine at UT Southwestern Medical Center, who was building a reputation as one of only a handful of specialists in Dallas-Fort Worth who could offer a highly complex procedure known as endoscopic submucosal dissection (ESD).
Alessandro Vasciaveo, PhD, joined Sanford Burnham Prebys as an assistant professor in computational biology and artificial intelligence in fall 2024. He uses his training and experience as a scientist and engineer to advance knowledge of human biology through research, and to identify novel treatments and cures for diseases.
Researchers at WashU Medicine shrink gastrointestinal tumors in mice using a yeast probiotic to deliver immunotherapy to the gut, offering a potentially novel strategy to target hard-to-reach gut cancers.
A new study from researchers at The University of Texas MD Anderson Cancer Center finds that, in healthy women, some breast cells that otherwise appear normal may contain chromosome abnormalities typically associated with invasive breast cancer. The findings question conventional thinking on the genetic origins of breast cancer, which could influence early cancer detection methods. The study, published today in Nature, discovered that at least 3% of normal cells from breast tissue in 49 healthy women contain a gain or loss of chromosomes, a condition known as aneuploidy, and that they expand and accumulate with age. This poses questions for our understanding of “normal” tissues, according to principal investigator Nicholas Navin, Ph.D., chair of Systems Biology.
Roswell Park experts representing various specialties will highlight innovative research and advancements in hematology and hematologic cancers at the 66th annual meeting of the American Society of Hematology (ASH), to be held December 7-10 in San Diego, California.
Showing results
1–1 of 1
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
